FDA inspection
Cadila Pharmaceuticals Limited: FDA inspection ending Sep 26, 2025
FDA inspection 1293740 · No Action Indicated (NAI) · Ahmedabad
Key facts
| Inspection ID | 1293740 |
|---|---|
| Firm | Cadila Pharmaceuticals Limited |
| FEI number | 3007684569 |
| Address | 1389 Trasad Road, Dholka |
| City | Ahmedabad |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Sep 26, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data